JP3662929B2 - ４−キノリノン誘導体又はその塩 - Google Patents

４−キノリノン誘導体又はその塩 Download PDF

Info

Publication number
JP3662929B2
JP3662929B2 JP50067196A JP50067196A JP3662929B2 JP 3662929 B2 JP3662929 B2 JP 3662929B2 JP 50067196 A JP50067196 A JP 50067196A JP 50067196 A JP50067196 A JP 50067196A JP 3662929 B2 JP3662929 B2 JP 3662929B2
Authority
JP
Japan
Prior art keywords
group
carbon atoms
atom
halogen atom
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP50067196A
Other languages
English (en)
Japanese (ja)
Inventor
和応 山崎
滋 阿出川
陽一郎 小川
秀明 松田
忠幸 倉石
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of JP3662929B2 publication Critical patent/JP3662929B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP50067196A 1994-06-09 1995-06-06 ４−キノリノン誘導体又はその塩 Expired - Fee Related JP3662929B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12757394 1994-06-09
PCT/JP1995/001118 WO1995033726A1 (fr) 1994-06-09 1995-06-06 Derive de 4-quinolinone ou sel de ce compose

Publications (1)

Publication Number Publication Date
JP3662929B2 true JP3662929B2 (ja) 2005-06-22

Family

ID=14963397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50067196A Expired - Fee Related JP3662929B2 (ja) 1994-06-09 1995-06-06 ４−キノリノン誘導体又はその塩

Country Status (8)

Country Link
US (1) US5789419A (OSRAM)
EP (1) EP0764639A4 (OSRAM)
JP (1) JP3662929B2 (OSRAM)
KR (1) KR100254106B1 (OSRAM)
CN (1) CN1065529C (OSRAM)
CA (1) CA2191245A1 (OSRAM)
TW (1) TW308587B (OSRAM)
WO (1) WO1995033726A1 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605597B1 (en) * 1999-12-03 2003-08-12 Cv Therapeutics, Inc. Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives
US6294522B1 (en) 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
CN103108868B (zh) 2010-06-07 2015-11-25 诺沃梅迪科斯有限公司 呋喃基化合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8414987D0 (en) * 1984-06-12 1984-07-18 Beecham Group Plc Active compounds
JPS61165760A (ja) * 1985-01-17 1986-07-26 Canon Inc 電子写真感光体
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
GB8916683D0 (en) * 1989-07-21 1989-09-06 Beecham Group Plc Novel compounds
TW224941B (OSRAM) * 1989-11-08 1994-06-11 Yamanouchi Pharma Co Ltd
US5175151A (en) * 1990-09-07 1992-12-29 Schering Corporation Antiviral compounds and antihypertensive compounds
US5401848A (en) * 1990-11-26 1995-03-28 E. R. Squibb & Sons, Inc. Indane and quinoline derivatives
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
EP0764639A1 (en) 1997-03-26
EP0764639A4 (en) 1997-10-01
TW308587B (OSRAM) 1997-06-21
KR100254106B1 (ko) 2000-05-01
CA2191245A1 (en) 1995-12-14
KR970703316A (ko) 1997-07-03
WO1995033726A1 (fr) 1995-12-14
US5789419A (en) 1998-08-04
CN1065529C (zh) 2001-05-09
CN1150420A (zh) 1997-05-21

Similar Documents

Publication Publication Date Title
US5716967A (en) Isoxazoline compounds as antiinflammatory agents
EP1133474B1 (en) 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
KR100264807B1 (ko) 혈관내막비후억제제
JPS61134379A (ja) アミノメチルオキソオキサゾリジニルベンゼン誘導体
JPH04178375A (ja) 新規なベンズオキサジン誘導体及びその中間体並びにその医薬
CA2075017A1 (fr) Nouvelles (isoquinolein-5 yl) sulfamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5679677A (en) Heterocyclic carbamates, process for their preparation and medicaments
EP0539154B1 (en) Acridine-1,8-dione-derivatives as therapeutic agents
WO2019196714A1 (zh) 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途
JP2006063064A (ja) 受容体作動剤
HU204802B (en) Process for producing new benzoxazine and benzthiazine derivatives and pharmaceutical compositions comprising such compounds
JP3662929B2 (ja) ４−キノリノン誘導体又はその塩
JPH0337554B2 (OSRAM)
JP2001511799A (ja) オキシド−スクアレンシクラーゼ阻害剤として有用なヘテロ環式化合物
JPH05339240A (ja) テトラヒドロイソキノリンアミド誘導体
JPH08188563A (ja) アントラニル酸誘導体
US5298503A (en) N-(isoquinolin-5-ylsulphonyl) azacycloalkanes
JPH05186458A (ja) 新規なベンゾピラン誘導体
RU2122000C1 (ru) Бензопираны, промежуточные соединения, фармацевтическая композиция и способ лечения
US5440036A (en) 1,4-benzoxazine derivatives
KR19990082494A (ko) 약학적 활성 화합물 및 이의 사용 방법
RU2142454C1 (ru) Производные 4-амино-3-ацилхинолина, способ их получения, фармацевтический препарат на их основе, способ получения фармацевтического препарата и промежуточное соединение
JPH045672B2 (OSRAM)
US5278158A (en) Oxazinobenzazole compounds
KR20000029897A (ko) 약학적활성화합물및그것의사용방법

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040921

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041014

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050124

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20050322

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20050325

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20050401

A72 Notification of change in name of applicant

Free format text: JAPANESE INTERMEDIATE CODE: A721

Effective date: 20050414

R154 Certificate of patent or utility model (reissue)

Free format text: JAPANESE INTERMEDIATE CODE: R154

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees